ArticleFrontiers in medicine2026
Successful management of amniotic fluid embolism with cardiac arrest and liver rupture: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amniotic fluid embolism (AFE) is an unpredictable and critical obstetric emergency. Although infrequent, it carries a significant risk of mortality. AFE is typically characterized by abrupt circulatory and respiratory failures, along with disseminated intravascular coagulation (DIC). Another rare complication during pregnancy is spontaneous liver rupture, which poses a serious danger to both the mother and the fetus. AFE generally manifests suddenly during labor, delivery, or shortly after childbirth and is believed to be triggered by the entry of amniotic fluid components into the mother's bloodstream. Spontaneous liver rupture is more frequently observed in individuals with gestational hypertension, eclampsia, or hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. We report the case of a 34-year-old woman (G2P1) with no previous history of hypertension, preeclampsia/eclampsia, or HELLP syndrome. Her delivery was planned for at 40 weeks and 2 days of gestation. During labor, there were sudden drops in fetal heart rate, followed by the emergence of frothy sputum and a loss of consciousness. Although an urgent cesarean section was performed due to a high suspicion of amniotic fluid embolism, the patient still experienced repeated respiratory and cardiac arrests, accompanied by severe postpartum hemorrhage after the surgery. With the aid of venovenous extracorporeal membrane oxygenation (ECMO), surgical exploration revealed a simultaneous liver rupture. Through a collaborative multidisciplinary approach, the patient eventually made a full recovery. The successful management of both AFE and spontaneous liver rupture during pregnancy is exceedingly rare. This report examines pertinent cases and delves into the underlying pathophysiological mechanisms to improve prevention, diagnosis, and treatment strategies for similar occurrences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.